Key drivers for each region include: for North America, high awareness of thyroid disorders, established healthcare infrastructure, and ongoing research; for Europe, growing demand for thyroid extract treatments, favorable reimbursement policies, and increasing collaborations between healthcare providers; for Asia Pacific, rising prevalence of thyroid disorders, expanding healthcare infrastructure, and growing investments in healthcare technology; for Latin America, increasing awareness of thyroid disorders, improving healthcare infrastructure, and growing demand for thyroid extract treatments; and for Middle East & Africa, growing healthcare infrastructure, increasing investments in healthcare technology, and rising demand for thyroid extract treatments.